Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 20;205(11):356.
doi: 10.1007/s00203-023-03699-2.

A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance

Affiliations
Review

A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance

Lei Chen et al. Arch Microbiol. .

Abstract

The emergence and transmission of antibiotic resistance is a global public health crisis with significant burden on healthcare systems, resulting in high mortality and economic costs. In 2019, almost five million deaths were associated with drug-resistant infections, and if left unchecked, the global economy could lose $100 trillion by 2050. To effectively combat this crisis, it is essential for all countries to understand the current situation of antibiotic resistance. In this review, we examine the current driving factors leading to the crisis, impact of critical superbugs in three regions, and identify novel mechanisms of antibiotic resistance. It is crucial to monitor the phenotypic characteristics of drug-resistant pathogens and describe the mechanisms involved in preventing the emergence of cross-resistance to novel antimicrobials. Additionally, maintaining an active pipeline of new antibiotics is essential for fighting against diverse antibiotic-resistant pathogens. Developing antibacterial agents with novel mechanisms of action is a promising way to combat increasing antibiotic-resistant pathogens.

Keywords: Antibiotic resistance; Factors; Impact; Mechanisms; Novel antibiotic candidates.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Al-Tawfiq JA, Momattin H, Al-Ali AY et al (2022) Antibiotics in the pipeline: a literature review (2017–2020). Infection 50:553–564. https://doi.org/10.1007/s15010-021-01709-3 - DOI - PubMed
    1. Andrei S, Droc G, Stefan G (2019) FDA approved antibacterial drugs: 2018–2019. Discoveries 7:e102. https://doi.org/10.15190/d.2019.15 - DOI - PubMed - PMC
    1. Asokan G, Ramadhan T, Ahmed E, Sanad H (2019) WHO global priority pathogens list: a bibliometric analysis of Medline-Pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J 34:184–193. https://doi.org/10.5001/omj.2019.37 - DOI - PubMed - PMC
    1. Ayikpoe RS, Shi C, Battiste AJ et al (2022) A scalable platform to discover antimicrobials of ribosomal origin. Nat Commun 13:6135. https://doi.org/10.1038/s41467-022-33890-w - DOI - PubMed - PMC
    1. Biswas S (2023) Synthesis of a novel lantibiotic using mutacin II biosynthesis apparatus. Microbiol Spectr. https://doi.org/10.1128/spectrum.03030-22 - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources